OCS

Oculis Holding AG

Healthcare›Biotechnology|NASDAQ Global Market|CH

Price

$26.63

Market Cap

$1.52B

Beta

0.21

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)+9.43%

Revenue CAGR 3Y+26.67%

P/E Ratio0.0

PEG Ratio—

FCF Yield-4.40%

Debt / Equity0.01

Interest Coverage-94.0x

No credit card required

Already have an account? Sign in to view the full analysis for OCS.